Table 2 Treatment outcome of AS-AQ versus AL at D42
Outcome | AS-AQ | AL | p value |
|---|---|---|---|
ITT Analysis | |||
Enrolled patients | 188 | 195 | |
Patients seen at day 42 | 182/188 (96.8%) | 193/195 (99%) | 0.13 |
Missing | 06/188 (3.2%) | 02/195 (1%) | 0.13 |
Crude failure rate at day 42 | 04/188 (2.1%) | 05/195 (2.6%) | 0.77 |
Crude cure rate at day 42 | 178/188 (94.7%) | 188/195 (96.4%) | 0.41 |
PCR adjusted failure rate at day 42 | 06/188 (3.2%) | 02/195 (1%) | 1 |
PCR adjusted cure rate at day 42 | 182/188 (96.8%) | 193/195 (99%) | 0.32 |
PP analysis | |||
Patients seen at day 42 | 182 | 193 | |
Crude failure rate at day 42 | 04/182 (02.2%) | 05/193 (2.6%) | 0.80 |
Crude cure rate at day 42 | 178/182 (97.8%) | 188/193 (97.4%) | 0.80 |
PCR adjusted failure rate at day 42 | 0/182 (0%) | 0/193 (0%) | 1 |
PCR adjusted cure rate at day 42 | 182/182 (100%) | 193/193 (100%) | 0.59 |